Author: Paulina Linares
06/03/2023
TREM2+ macrophages suppress CD8+ T cell infiltration after transarterial chemoembolization in hepatocellular carcinoma
Background & aims: The immune landscape of hepatocellular carcinoma (HCC) following transarterial [...]
Read more01/03/2023
Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
Liver cancer is a major cause of cancer mortality worldwide. Screening individuals at high risk, including [...]
Read more06/02/2023
Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity
Cellular senescence involves a stable cell-cycle arrest coupled to a secretory program that, in some [...]
Read more09/01/2023
Assessment of response to liver directed radiation-based therapies: Current guidelines, challenges, and future directions
Radiation-based local-regional therapies for hepatocellular carcinoma (HCC) have gained wide acceptance due [...]
Read more26/12/2022
Artificial intelligence and its role in guiding liver-directed therapy for hepatocellular carcinoma: Is it ready for prime time?
Artificial intelligence (AI) is an innovative discipline in medicine, impacting both hepatology and [...]
Read more17/11/2022
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide and is an [...]
Read more14/10/2022
Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance
Human immunodeficiency virus (HIV) and hepatitis-B virus (HBV) infections are weighty public health [...]
Read more12/10/2022
Sonography in surveillance for HCC in NAFLD patients
Over the last decade, we have been facing a new aetiology responsible for the development of HCC – [...]
Read more08/10/2022
Old-fashioned and newly discovered biomarkers: the future of NAFLD-related HCC screening and monitoring
Nonalcoholic fatty liver disease (NAFLD) is the major contributor to the global burden of chronic liver [...]
Read more23/09/2022
Cancer stem cell-mediated therapeutic resistance in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a highly heterogeneous malignancy. In the clinic, therapeutic resistance [...]
Read more